Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)
ASENT 20th Annual Meeting March 7-10, 2018 Location Hilton Washington DC/Rockvile Hotel & Executive Meeting Center 1750 Rockville Pike Rockville, Maryland 20852
Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results
Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and Corporate Highlights on Wednesday, February 7, 2018
Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference
San Francisco, January 8th through 11th at the J.P. Morgan Healthcare Conference. Anavex is attending the 36th annual J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry.
Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs
Efficacy of ANAVEX 2-73, a Sigma-1 receptor agonist, in the MECP2 mouse model of Rett syndrome